Login / Signup

Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19.

Pandora L WanderElliott LowyLauren A BesteLuis Tulloch-PalominoAnna KorpakAlexander C PetersonSteven E KahnEdward J Boyko
Published in: Diabetes care (2021)
Among veterans with diabetes and COVID-19, higher HbA1c and insulin use were directly associated with adverse outcomes, while use of a GLP1-RA, metformin, and SGLT2i was inversely associated.
Keyphrases